Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease

Abstract

HIV-associated MCD is a remitting-relapsing disease. The outlook has improved dramatically in recent years with the introduction of rituximab-based therapy and yields high overall survival rates.